Suvretta Capital Management, LLC
Director at Veradermics; Director at Benitec Biopharma.
- Rank
- 686th of 813
- Companies held
- 2
- Largest holding
- MANE, 81.4% of total
- Latest SEC filing
- Feb 6, 2026
What the $79.6M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Veradermics MANE Common stock, par value $0.00001 per share | Indirectly (see filing footnote) | 520,453 | $124.39 | $64.7M | 81.4% | Form 4, Feb 6, 2026 |
| Benitec Biopharma BNTC Common stock, par value $0.0001 per share | Indirectly (see filing footnote) | 1,819,812 | $8.14 | $14.8M | 18.6% | Form 4, Nov 7, 2025 |
Share counts are the amounts Suvretta Capital Management, LLC reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Feb 6, 2026 | Bought | MANE | 11,183 | $35.97 | $402K | View |
| Feb 6, 2026 | Bought | MANE | 19,338 | $36.55 | $707K | View |
| Feb 5, 2026 | Bought | MANE | 3,832 | $36.07 | $138K | View |
| Feb 5, 2026 | Bought | MANE | 19,199 | $36.93 | $709K | View |
| Feb 5, 2026 | Bought | MANE | 38,771 | $37.63 | $1.5M | View |
| Feb 5, 2026 | Bought | MANE | 17,835 | $38.67 | $690K | View |
| Feb 5, 2026 | Bought | MANE | 16,563 | $39.80 | $659K | View |
| Feb 4, 2026 | Bought | MANE | 3,178 | $38.90 | $124K | View |
| Feb 4, 2026 | Bought | MANE | 10,004 | $34.25 | $343K | View |
| Feb 4, 2026 | Bought | MANE | 10,676 | $34.74 | $371K | View |
| Feb 4, 2026 | Bought | MANE | 14,659 | $36.27 | $532K | View |
| Feb 4, 2026 | Bought | MANE | 53,344 | $37.11 | $2.0M | View |
| Feb 4, 2026 | Bought | MANE | 25,908 | $38.09 | $987K | View |
| Feb 4, 2026 | Bought | MANE | 18,489 | $38.90 | $719K | View |
| Feb 4, 2026 | Bought | MANE | 1,720 | $34.25 | $59K | View |
| Feb 4, 2026 | Bought | MANE | 1,835 | $34.74 | $64K | View |
| Feb 4, 2026 | Bought | MANE | 2,519 | $36.27 | $91K | View |
| Feb 4, 2026 | Bought | MANE | 9,168 | $37.11 | $340K | View |
| Feb 4, 2026 | Bought | MANE | 4,453 | $38.09 | $170K | View |
| Nov 7, 2025 | Bought | BNTC | 751,111 | $13.50 | $10.1M | View |
| Nov 7, 2025 | Bought | BNTC | 730,370 | $13.50 | $9.9M | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 683 | Technology Impact Fund, LP 10% owner, Fervo Energy | $80.3M |
| 684 | Infinite Acquisitions Partners LLC 10% owner, Falcon's Beyond Global | $79.9M |
| 685 | Avalon Ventures XI, L.P. 10% owner, Janux Therapeutics | $79.8M |
| 686 | Suvretta Capital Management, LLC Director, Veradermics | $79.6M |
| 687 | Insight Venture Partners X, L.P. 10% owner, Hinge Health | $79.0M |
| 688 | Suntx Capital Partners L P Director, Construction Partners | $78.8M |
| 689 | Prestige Century Investments Ltd 10% owner, Ivanhoe Electric | $78.8M |
Other Veradermics insiders
All MANE insiders- John W. Childs$261MDirector. #539 overall
- Vlad Coric$88.3MDirector. #1155 overall
- Timothy August Durso$24.2MChief Technical Officer. #4480 overall
- Reid Alexander Waldman$21.2MChief Executive Officer. #4956 overall
Questions
How much stock does Suvretta Capital Management, LLC own?
Suvretta Capital Management, LLC holds $79,552,418 in listed stock based on SEC filings and current prices, mostly Veradermics (MANE). That ranks 686th on the Stock Rich List.
Is this Suvretta Capital Management, LLC's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Suvretta Capital Management, LLC last buy or sell stock?
The most recent open-market trade on file is a purchase of 11,183 MANE shares on Feb 6, 2026 at $35.97.
Files jointly with SEC filer 1869640.